[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Neurological Biomarkers Market Report 2017

December 2017 | 112 pages | ID: A66A5724E39EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Neurological Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Neurological Biomarkers for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Neurological Biomarkers market competition by top manufacturers/players, with Neurological Biomarkers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Thermo Fisher Scientific (U.S.)
  • Qiagen (Germany)
  • Myriad RBM (U.S.)
  • Proteome Sciences (UK)
  • Banyan Biomarkers (U.S.)
  • Cisbio Bioassays (U.S.)
  • Abiant (U.S.)
  • Acumen Pharmaceuticals (U.S.)
  • Proteosys (Germany)
  • Alseres Pharmaceuticals (U.S.)
  • Athena Diagnostics (U.S.)
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Alzheimer's Disease
  • Parkinson's Disease
  • Autism Spectrum Disorder
  • Multiple Sclerosis
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Genomics
  • Proteomics
  • Metabolomics
  • Imaging
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Neurological Biomarkers Market Report 2017

1 NEUROLOGICAL BIOMARKERS OVERVIEW

1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers by Product Category
  1.2.1 Asia-Pacific Neurological Biomarkers Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Neurological Biomarkers Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Alzheimer's Disease
  1.2.4 Parkinson's Disease
  1.2.5 Autism Spectrum Disorder
  1.2.6 Multiple Sclerosis
  1.2.7 Other
1.3 Asia-Pacific Neurological Biomarkers Market by Application/End Users
  1.3.1 Asia-Pacific Neurological Biomarkers Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Genomics
  1.3.3 Proteomics
  1.3.4 Metabolomics
  1.3.5 Imaging
  1.3.6 Other
1.4 Asia-Pacific Neurological Biomarkers Market by Region
  1.4.1 Asia-Pacific Neurological Biomarkers Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Neurological Biomarkers (2012-2022)
  1.5.1 Asia-Pacific Neurological Biomarkers Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Neurological Biomarkers Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Neurological Biomarkers Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Neurological Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Neurological Biomarkers (Volume and Value) by Type
  2.2.1 Asia-Pacific Neurological Biomarkers Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Neurological Biomarkers (Volume) by Application
2.4 Asia-Pacific Neurological Biomarkers (Volume and Value) by Region
  2.4.1 Asia-Pacific Neurological Biomarkers Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Neurological Biomarkers Revenue and Market Share by Region (2012-2017)

3 CHINA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

3.1 China Neurological Biomarkers Sales and Value (2012-2017)
  3.1.1 China Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  3.1.3 China Neurological Biomarkers Sales Price Trend (2012-2017)
3.2 China Neurological Biomarkers Sales Volume and Market Share by Type
3.3 China Neurological Biomarkers Sales Volume and Market Share by Application

4 JAPAN NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Neurological Biomarkers Sales and Value (2012-2017)
  4.1.1 Japan Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Neurological Biomarkers Sales Price Trend (2012-2017)
4.2 Japan Neurological Biomarkers Sales Volume and Market Share by Type
4.3 Japan Neurological Biomarkers Sales Volume and Market Share by Application

5 SOUTH KOREA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Neurological Biomarkers Sales and Value (2012-2017)
  5.1.1 South Korea Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Neurological Biomarkers Sales Price Trend (2012-2017)
5.2 South Korea Neurological Biomarkers Sales Volume and Market Share by Type
5.3 South Korea Neurological Biomarkers Sales Volume and Market Share by Application

6 TAIWAN NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Neurological Biomarkers Sales and Value (2012-2017)
  6.1.1 Taiwan Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Neurological Biomarkers Sales Price Trend (2012-2017)
6.2 Taiwan Neurological Biomarkers Sales Volume and Market Share by Type
6.3 Taiwan Neurological Biomarkers Sales Volume and Market Share by Application

7 INDIA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

7.1 India Neurological Biomarkers Sales and Value (2012-2017)
  7.1.1 India Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  7.1.3 India Neurological Biomarkers Sales Price Trend (2012-2017)
7.2 India Neurological Biomarkers Sales Volume and Market Share by Type
7.3 India Neurological Biomarkers Sales Volume and Market Share by Application

8 SOUTHEAST ASIA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Neurological Biomarkers Sales and Value (2012-2017)
  8.1.1 Southeast Asia Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Neurological Biomarkers Sales Price Trend (2012-2017)
8.2 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Type
8.3 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Application

9 AUSTRALIA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Neurological Biomarkers Sales and Value (2012-2017)
  9.1.1 Australia Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Neurological Biomarkers Sales Price Trend (2012-2017)
9.2 Australia Neurological Biomarkers Sales Volume and Market Share by Type
9.3 Australia Neurological Biomarkers Sales Volume and Market Share by Application

10 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Thermo Fisher Scientific (U.S.)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Neurological Biomarkers Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Qiagen (Germany)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Neurological Biomarkers Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Qiagen (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Myriad RBM (U.S.)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Neurological Biomarkers Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Myriad RBM (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Proteome Sciences (UK)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Neurological Biomarkers Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Proteome Sciences (UK) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Banyan Biomarkers (U.S.)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Neurological Biomarkers Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Banyan Biomarkers (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Cisbio Bioassays (U.S.)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Neurological Biomarkers Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Cisbio Bioassays (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Abiant (U.S.)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Neurological Biomarkers Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Abiant (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Acumen Pharmaceuticals (U.S.)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Neurological Biomarkers Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Proteosys (Germany)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Neurological Biomarkers Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Proteosys (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Alseres Pharmaceuticals (U.S.)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Neurological Biomarkers Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Athena Diagnostics (U.S.)

11 NEUROLOGICAL BIOMARKERS MANUFACTURING COST ANALYSIS

11.1 Neurological Biomarkers Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Neurological Biomarkers

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Neurological Biomarkers Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Neurological Biomarkers Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Neurological Biomarkers Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Neurological Biomarkers Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Neurological Biomarkers Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Neurological Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Neurological Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Neurological Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Neurological Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Neurological Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Neurological Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Neurological Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Neurological Biomarkers Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Neurological Biomarkers Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Neurological Biomarkers Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Neurological Biomarkers Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Neurological Biomarkers Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Neurological Biomarkers
Figure Asia-Pacific Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Neurological Biomarkers Sales Volume Market Share by Type (Product Category) in 2016
Figure Alzheimer's Disease Product Picture
Figure Parkinson's Disease Product Picture
Figure Autism Spectrum Disorder Product Picture
Figure Multiple Sclerosis Product Picture
Figure Other Product Picture
Figure Asia-Pacific Neurological Biomarkers Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Neurological Biomarkers by Application in 2016
Figure Genomics Examples
Table Key Downstream Customer in Genomics
Figure Proteomics Examples
Table Key Downstream Customer in Proteomics
Figure Metabolomics Examples
Table Key Downstream Customer in Metabolomics
Figure Imaging Examples
Table Key Downstream Customer in Imaging
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Neurological Biomarkers Market Size (Million USD) by Region (2012-2022)
Figure China Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Neurological Biomarkers Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Neurological Biomarkers Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Neurological Biomarkers Sales Share by Players/Suppliers
Figure Asia-Pacific Neurological Biomarkers Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Neurological Biomarkers Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Neurological Biomarkers Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Neurological Biomarkers Revenue Share by Players
Figure 2017 Asia-Pacific Neurological Biomarkers Revenue Share by Players
Table Asia-Pacific Neurological Biomarkers Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Share by Type (2012-2017)
Figure Sales Market Share of Neurological Biomarkers by Type (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Neurological Biomarkers Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Neurological Biomarkers Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Type (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Share by Region (2012-2017)
Figure Sales Market Share of Neurological Biomarkers by Region (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Region in 2016
Table Asia-Pacific Neurological Biomarkers Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Neurological Biomarkers Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Region (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Region in 2016
Table Asia-Pacific Neurological Biomarkers Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure China Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table China Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table China Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure China Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table China Neurological Biomarkers Sales Volume (K Pcs) by Applications (2012-2017)
Table China Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure China Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure Japan Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure Japan Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table Japan Neurological Biomarkers Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure Japan Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure South Korea Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure South Korea Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table South Korea Neurological Biomarkers Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure South Korea Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure Taiwan Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table Taiwan Neurological Biomarkers Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure India Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table India Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table India Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure India Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table India Neurological Biomarkers Sales Volume (K Pcs) by Application (2012-2017)
Table India Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure India Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure Southeast Asia Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table Southeast Asia Neurological Biomarkers Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure Australia Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure Australia Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table Australia Neurological Biomarkers Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure Australia Neurological Biomarkers Sales Volume Market Share by Application in 2016
Table Thermo Fisher Scientific (U.S.) Neurological Biomarkers Basic Information List
Table Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Qiagen (Germany) Neurological Biomarkers Basic Information List
Table Qiagen (Germany) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Myriad RBM (U.S.) Neurological Biomarkers Basic Information List
Table Myriad RBM (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Proteome Sciences (UK) Neurological Biomarkers Basic Information List
Table Proteome Sciences (UK) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Banyan Biomarkers (U.S.) Neurological Biomarkers Basic Information List
Table Banyan Biomarkers (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Cisbio Bioassays (U.S.) Neurological Biomarkers Basic Information List
Table Cisbio Bioassays (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Abiant (U.S.) Neurological Biomarkers Basic Information List
Table Abiant (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Basic Information List
Table Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Proteosys (Germany) Neurological Biomarkers Basic Information List
Table Proteosys (Germany) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Basic Information List
Table Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales Market Share in Asia-Pacific (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Revenue Market Share in Asia-Pacific (2012-2017)
Table Athena Diagnostics (U.S.) Neurological Biomarkers Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure Manufacturing Process Analysis of Neurological Biomarkers
Figure Neurological Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
Table Major Buyers of Neurological Biomarkers
Table Distributors/Traders List
Figure Asia-Pacific Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Neurological Biomarkers Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Neurological Biomarkers Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Region in 2022
Figure China Neurological Biomarkers Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Neurological Biomarkers Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Neurological Biomarkers Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Neurological Biomarkers Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Neurological Biomarkers Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Neurological Biomarkers Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Neurological Biomarkers Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Neurological Biomarkers Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Neurological Biomarkers Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Neurological Biomarkers Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Neurological Biomarkers Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories